Access Biotechnology — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Passage Biopassagebio.comin𝕏NASDAQ: PASGAug 2019
Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions.
BiotechHealthtechPhiladelphia, US
Tadataka Yamada(Executive Officer, Director, Promoter)Stephen Squinto(Executive Officer, Director)
BoardPatrick Heron(Director)inCarl Gordon(Director)Thomas Street Address 1 Woiwode(Director)Saqib Islam(Director)
Co-investorsFrazier Life SciencesFrazier Healthcare PartnersNew Leaf Venture PartnersOrbiMedVersant VenturesVivo Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.